Hasil Pencarian - Lova Sun

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer

    Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer oleh Lova Sun, MD, Charu Aggarwal, MD, MPH, Roger B. Cohen, MD

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A novel pipeline for prioritizing cancer type‐specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas

    A novel pipeline for prioritizing cancer type‐specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas oleh Malay K. Sannigrahi, Austin C. Cao, Pavithra Rajagopalan, Lova Sun, Robert M. Brody, Lovely Raghav, Phyllis A. Gimotty, Devraj Basu

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    681 innovaTV 207 Parts E and F: a phase 2 study of tisotumab vedotin in patients with head and neck squamous cell carcinoma (trial in progress)

    681 innovaTV 207 Parts E and F: a phase 2 study of tisotumab vedotin in patients with head and neck squamous cell carcinoma (trial in progress) oleh Christine H Chung, Lara A Dunn, Ibrahima Soumaoro, Leonardo Nicacio, Dan P Zandberg, Douglas Adkins, Tanguy Y Seiwert, Nabil F Saba, Lova Sun, Thomas J George, William N William, Kristi Schmidt

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.

    Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. oleh Daniel Y Joh, Lova Sun, Melissa Stangl, Ajlan Al Zaki, Surya Murty, Phillip P Santoiemma, James J Davis, Brian C Baumann, Michelle Alonso-Basanta, Dongha Bhang, Gary D Kao, Andrew Tsourkas, Jay F Dorsey

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC

    Characteristics of Long-Term Survivors With EGFR-Mutant Metastatic NSCLC oleh William Tompkins, MD, Connor B. Grady, MPH, Wei-Ting Hwang, PhD, Krishna Chandrasekhara, Caroline McCoach, MD, Fangdi Sun, MD, Geoffrey Liu, MD, Devalben Patel, MD, Jorge Nieva, MD, Amanda Herrmann, MD, Kristen Marrone, MD, Vincent K. Lam, MD, Vamsi Velcheti, MD, Stephen V. Liu, MD, Gabriela Liliana Bravo Montenegro, MD, Tejas Patil, MD, Jared Weiss, MD, Kelsey Leigh Miller, MD, William Schwartzman, MD, Jonathan E. Dowell, MD, Khvaramze Shaverdashvili, MD, Liza Villaruz, MD, Amanda Cass, PharmD, Wade Iams, MD, Dara Aisner, MD, PhD, Charu Aggarwal, MD, D. Ross Camidge, MD, PhD, Melina E. Marmarelis, MD, Lova Sun, MD

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: